Responses
Clinical/translational cancer immunotherapy
Original research
Reconstruction of unreported subgroup survival data with PD-L1-low expression in advanced/metastatic triple-negative breast cancer using innovative KMSubtraction workflow
Compose a Response to This Article
Other responses
No responses have been published for this article.
